Dear , 
Last month we announced 5 new winners of our MPN Challenge grant program. Click here to read about them and their projects. We'll have updates on the progress of past year's grantees soon. Also, look for our bi-annual MPN Update newsletter in your mailbox soon. If you aren't sure we have your updated mailing address simply send us an email here with where we should send it. 

There are many events coming up for people with PV, ET and MF. Whether you are newly diagnosed, a long time patient or a caregiver, these are a great way to connect with others going through the same thing as well as learn more about how to best live with your MPN. Please read on for a few events coming up (plus a chance to nominate an MPN hero in your life). 


Michelle Woehrle
Executive Director
Upcoming events for MPN patients

Nominate an MPN Hero today! 
Recognize individuals, institutions, and organizations who act above and beyond in their efforts to support patients with MPN.

Are you a Woman living with PV, ET or MF? 
You are invited to an MPN event focused on you in Los Angeles, California Friday, September 29, 2017

 for the the 9TH International Patient Symposium on MPNs
Wednesday, Nov 1, 2017
Griffis Faculty Club, Weill Cornell Medical College
521 East 68th Street  New York, NY  10065

ASU working with Mayo Clinic on Fitbit symptom and QOL study
Dr. Jennifer Huberty, an Associate Professor of Exercise and Wellness at ASU and Dr. Ruben Mesa (Mayo Clinic) are conducting a research study to explore the effects of a mobile-application health  intervention on the MPN patient symptom burden (e.g., pain, fatigue, depression, anxiety, and sleep) and quality of life.  Click here for more information about this study.
Clinical trial now recruiting

A safety and efficacy study to evaluate luspatercept in subjects with myeloproliferative neoplasm-associated myelofibrosis who have anemia with and without red blood cell-transfusion dependence

First patient enrolls in Pacritinib trial

CTI BioPharma Announces First Patient Enrolled in Phase 2 Trial of Pacritinib in Patients with Myelofibrosis who have Thrombocytopenia and who have been Previously Treated with Ruxolitinib  

Like us on Facebook  Follow us on Twitter  View on Instagram